September 24, 2026

【JANCO Business Outlook】Pharmaceutical & Healthcare

Compliance as the Foundation
Dual Engines Drive a New Landscape in Pharma
Connecting Global Pharmaceuticals
Intelligently Initiating a New Chapter for Hong Kong's Health

‍

Building on our steady turnaround, JANCO advances confidently. Our Pharmaceutical & Healthcare division is poised to expand across the full value chain, embracing the boundless opportunities of the health era.

Hong Kong’s 2026/27 Budget promotes life and health technology development, positioning the city as a global hub for medical innovation. As an accredited logistics provider for the Hospital Authority, JANCO stands at the forefront of this growth with internationally compliant qualifications and reliable cold-chain expertise.

💊 Core Strength — Compliance Fortress

Licensed by Hong Kong’s Department of Health, JANCO provides antibiotic handling and secondary drug packaging services. Our advanced temperature‑controlled logistics ensure precision and reliability for vaccines and biologics, ready for rising market demand.

Hospitals and clinics under the Hospital Authority are now covered by our logistics service, handling medicines, medical equipment, and even patient meals. Our fleet fully meets eco standards, with EV trucks already in daily use — combining efficiency with sustainability.

🚀 Dual‑Engine Strategy : Import & API Supply Chain

Looking ahead, we pursue steady growth through a dual‑engine approach :

Finished Drugs & Agency Import

We act as a two‑way bridge: introducing high‑quality medicines into Hong Kong under strict registration, patent, and sales requirements, while expanding overseas agency partnerships. By aligning compliance, licensing, cold‑chain capability, and market insight, we are prepared for Hong Kong’s pharmaceutical upgrade and global supply chain restructuring. This strategy shows long‑term growth potential, ready to capture opportunities with partners.

API Supply Chain

Supporting industry restructuring, we connect international API suppliers and leverage Hong Kong’s free‑port and logistics advantages. Gradually extending from drug agency into upstream pharmaceutical supply, we enhance value‑chain synergy and establish a new pillar for long‑term industry resilience.

Building Compliance, Shaping the Future

Rooted in Hong Kong, connected globally - JANCO continues to strengthen its compliant foundation and seize opportunities in the evolving medical supply chain, driving enduring innovation and growth.

‍

Recent Blog

View all blogs
More Templates